<DOC>
	<DOC>NCT00288691</DOC>
	<brief_summary>The aim of this study is to explore effects of the investigational product for the treatment of treatment-resistant menorrhagia without organic cause.</brief_summary>
	<brief_title>Menorrhagia Study in Women With Treatment-resistant Menorrhagia</brief_title>
	<detailed_description>The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.</detailed_description>
	<mesh_term>Menorrhagia</mesh_term>
	<criteria>Patients with treatmentresistant menorrhagia scheduled for hysterectomy. Organic causes of menorrhagia Current hormone treatment</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Treatment-resistant menorrhagia</keyword>
</DOC>